BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16150576)

  • 21. Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study.
    Tamagaki C; Sedvall GC; Jönsson EG; Okugawa G; Hall H; Pauli S; Agartz I
    Am J Psychiatry; 2005 Dec; 162(12):2315-21. PubMed ID: 16330596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.
    Machielsen MWJ; Veltman DJ; van den Brink W; de Haan L
    Schizophr Res; 2018 Apr; 194():32-38. PubMed ID: 28351544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
    Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
    Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes.
    Mitelman SA; Shihabuddin L; Brickman AM; Hazlett EA; Buchsbaum MS
    Am J Psychiatry; 2003 Dec; 160(12):2154-68. PubMed ID: 14638586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
    Glenthoj A; Glenthoj BY; Mackeprang T; Pagsberg AK; Hemmingsen RP; Jernigan TL; Baaré WF
    Psychiatry Res; 2007 Apr; 154(3):199-208. PubMed ID: 17360162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients.
    Liu N; Xiao Y; Zhang W; Tang B; Zeng J; Hu N; Chandan S; Gong Q; Lui S
    Transl Psychiatry; 2020 May; 10(1):136. PubMed ID: 32398765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes.
    Arango C; Breier A; McMahon R; Carpenter WT; Buchanan RW
    Am J Psychiatry; 2003 Aug; 160(8):1421-7. PubMed ID: 12900303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients.
    Lee YM; Park JM; Lee BD; Moon E; Jeong HJ; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    J Clin Psychiatry; 2016 Jan; 77(1):e8-13. PubMed ID: 26845282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated.
    Luo C; Lencer R; Hu N; Xiao Y; Zhang W; Li S; Lui S; Gong Q
    Int J Neuropsychopharmacol; 2020 Dec; 23(12):799-810. PubMed ID: 32808036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia.
    Mitelman SA; Brickman AM; Shihabuddin L; Newmark RE; Hazlett EA; Haznedar MM; Buchsbaum MS
    Neuroimage; 2007 Aug; 37(2):449-62. PubMed ID: 17587598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study].
    Mazza M; Tozzini C; Giosué P; De Risio A; Palmucci M; Roncone R; Casacchia M
    Clin Ter; 2003; 154(2):79-83. PubMed ID: 12856365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atypical neuroleptics and selective attention].
    Stip E; Lussier I; Lalonde P; Luyet A; Fabian J
    Encephale; 1999; 25(3):260-4. PubMed ID: 10434152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.
    Goghari VM; Smith GN; Honer WG; Kopala LC; Thornton AE; Su W; Macewan GW; Lang DJ
    Schizophr Res; 2013 Sep; 149(1-3):149-55. PubMed ID: 23830856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
    Honer WG; Thornton AE; Chen EY; Chan RC; Wong JO; Bergmann A; Falkai P; Pomarol-Clotet E; McKenna PJ; Stip E; Williams R; MacEwan GW; Wasan K; Procyshyn R;
    N Engl J Med; 2006 Feb; 354(5):472-82. PubMed ID: 16452559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corpus callosum volumes in the 5 years following the first-episode of schizophrenia: Effects of antipsychotics, chronicity and maturation.
    de Moura MTM; Zanetti MV; Duran FLS; Schaufelberger MS; Menezes PR; Scazufca M; Busatto GF; Serpa MH
    Neuroimage Clin; 2018; 18():932-942. PubMed ID: 29876278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.